Professional Medical Expertise (9574) Fundamentals 2026 — P/E 7.0x, Revenue Analysis | SniperIQ
Professional Medical Expertise (9574) is a SA-listed Healthcare company in Medical - Distribution with a market capitalization of SAR 294M, trading at SAR 84.00 on the SAU. This SniperIQ fundamentals page covers Professional Medical Expertise's valuation (P/E 7.0x, P/B 2.0x), profitability (net margin 10.0%), revenue (SAR 419M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Professional Medical Expertise's market cap?
Professional Medical Expertise (9574) has a market capitalization of approximately SAR 294M, trading at SAR 84.00 on the SAU. Market cap moves with the live share price.
What is Professional Medical Expertise's P/E ratio?
Professional Medical Expertise's trailing twelve-month P/E ratio is 7.0x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Professional Medical Expertise?
Professional Medical Expertise runs a net profit margin of 10.0%, a gross margin of 44.2%, and an operating margin of 14.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Professional Medical Expertise generate?
Professional Medical Expertise reported revenue of SAR 419M for fiscal year 2025, with net income of SAR 42M and earnings per share (EPS) of 11.92. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Professional Medical Expertise pay a dividend?
Professional Medical Expertise offers a trailing dividend yield of about 1.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Professional Medical Expertise financially healthy?
Professional Medical Expertise carries a debt-to-equity ratio of 0.84x and a current ratio of 1.55x, with a market beta of -0.17. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Professional Medical Expertise a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Professional Medical Expertise (9574) the key facts are: market cap SAR 294M, P/E 7.0x, revenue SAR 419M, 52-week range 75-107. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Professional Medical Expertise's full fundamentals live
Get Professional Medical Expertise's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.